<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The clinical doubling times of human <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> are reviewed </plain></SENT>
<SENT sid="1" pm="."><plain>Methods are also described for estimating subclinical <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> doubling times, and these methods are applied to <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e>, <z:hpo ids='HP_0100768'>choriocarcinoma</z:hpo>, <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt's tumor</z:e>, and <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Rapidly growing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are often responsive to therapy, and such complete responses are often quite durable </plain></SENT>
<SENT sid="3" pm="."><plain>Slowly growing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> respond less favorably to therapy, and responses are generally not durable </plain></SENT>
<SENT sid="4" pm="."><plain>Rapidly growing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in advanced stages are similar in their response behavior to the slowly growing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>A strategy based on cell kinetics principles and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> doubling time data is proposed for improving therapeutic results in responsive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Data on clinical and subclinical <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> doubling times are used to distinguish early recurrences from late recurrences in a given <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type </plain></SENT>
<SENT sid="7" pm="."><plain>Early recurrences call for intensification of induction therapy, whereas late recurrences call for prolongation of consolidative therapy </plain></SENT>
<SENT sid="8" pm="."><plain>This strategy may also apply in adjuvant therapy of slowly growing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>